CryoPort/CYRX

$16.89

-0.71%
-
1D1W1MYTD1YMAX

About CryoPort

Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.

Ticker

CYRX

Sector

Industrials

Trading on

NASDAQ

Industry

Misc. Transportation

CEO

Jerrell Shelton

Employees

1,019

Headquarters

Brentwood, United States

CryoPort Metrics

BasicAdvanced
$836.78M
Market cap
-
P/E ratio
-$2.20
EPS
1.59
Beta
-
Dividend rate
$836.78M
1.58903
$24.17
$9.00
442.37K
11.732
11.158
77.878
77.967
-9.98%
-21.51%
-10.43%
3.587
1.801
4.493
-1.7%
-136.73%
43.65%

What the Analysts think about CryoPort

Analyst Ratings

Majority rating from 10 analysts.
Buy

Price Targets

Average projection from 9 analysts.
8.53% upside
High $22.00
Low $15.00
$16.89
Current price
$18.33
Average price target

CryoPort Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-108.91% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$57.2M
1.96%
Net income
$-62.3M
371.97%
Profit margin
-108.91%
363.05%

CryoPort Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 347.56%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.16
-$0.42
-$0.31
-$1.31
-
Expected
-$0.19
-$0.24
-$0.31
-$0.29
-$0.35
Surprise
-14.79%
77.63%
1.64%
347.56%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for CryoPort stock?

CryoPort (CYRX) has a market cap of $836.78M as of April 17, 2024.

What is the P/E ratio for CryoPort stock?

The price to earnings (P/E) ratio for CryoPort (CYRX) stock is 0 as of April 17, 2024.

Does CryoPort stock pay dividends?

No, CryoPort (CYRX) stock does not pay dividends to its shareholders as of April 17, 2024.

When is the next CryoPort dividend payment date?

CryoPort (CYRX) stock does not pay dividends to its shareholders.

What is the beta indicator for CryoPort?

CryoPort (CYRX) has a beta rating of 1.59. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the CryoPort stock price target?

The target price for CryoPort (CYRX) stock is $18.33, which is 8.53% above the current price of $16.89. This is an average based on projections from 9 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell CryoPort stock

Buy or sell CryoPort stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing